explore -WSS

explore

author：leisure time 2025-09-30 17:45:55 - browse：8798

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Dairy farmers resist CDC push for PPE against bird flu virus

hotspot

WSS

Google says AlphaFold 3 can map a vast universe of biomolecules

HHS leader on health, climate change and biopharma emissions

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Making AI in medicine accessible to smaller, and rural hospitals

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Hospital price transparency does save money, advocate argues

knowledge

explore

knowledge

Sports medicine is finally prioritizing gender equality

STAT Summit: How a Chicago ER doctor tackles gun violence

Activists slam private health insurers over coverage restrictions

Senate committee scrutinizes Medicare Advantage brokers

Medical records are filled with copy

Why health workers in Gaza are injured or die at high rates

Dobbs anniversary: the lost opportunity of abortion as health care

After gene therapy, two congenitally deaf children hear for the first time

Activists slam private health insurers over coverage restrictions

Sanofi strikes deal with Novavax, boosting the vaccine maker

hotspot

First Opinion Podcast: Long Covid needs a new approach

Impact of Dobbs ruling felt at reproductive medicine meeting

What nurses really want: sufficient staffing for patient care

STAT Readout Newsletter: Today's biggest biotech updates

Steward Health Care files for bankruptcy

Medicare says breakthrough device reimbursement rule to come by summer

entertainment

focus

hotspot

entertainment